Terug
Dagbereik
€ 7,60
€ 8,48
52-Weeksbereik
€ 6,66
€ 18,90
Volume
1.754.266
50D / 200D Gem.
€ 9,69
/
€ 11,76
Vorige Slotkoers
€ 8,17
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,5 | 0,4 |
| P/B | 6,7 | 2,9 |
| ROE % | -92,3 | 3,8 |
| Net Margin % | -203,3 | 3,9 |
| Rev Growth 5Y % | 97,8 | 10,0 |
| D/E | 0,9 | 0,2 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 |
Dorsey Brian
Chief Operating Officer
|
grant | 240.000 | — | — |
| Jan 2, 2026 |
Chakma Justin
Chief Business Officer
|
grant | 240.000 | — | — |
| Jan 2, 2026 |
Scott Kathleen D.
Chief Financial Officer
|
grant | 240.000 | — | — |
| Jan 2, 2026 |
Lowenthal Richard E
PRESIDENT AND CEO
|
grant | 1.115.000 | — | — |
| Jan 2, 2026 |
Tanimoto Sarina
CHIEF MEDICAL OFFICER
|
grant | 1.115.000 | — | — |
| Nov 13, 2025 |
Dorsey Brian
Chief Operating Officer
|
other | 43.656 | € 0,64 | — |
| Nov 13, 2025 |
Dorsey Brian
Chief Operating Officer
|
sell | 21.828 | € 8,71 | € 190.050 |
| Aug 21, 2025 |
Scott Kathleen D.
Chief Financial Officer
|
other | 25.000 | € 1,50 | — |
| Aug 21, 2025 |
Scott Kathleen D.
Chief Financial Officer
|
sell | 12.500 | € 15,00 | € 187.500 |
| Jul 1, 2025 |
Karas Eric
Chief Commercial Officer
|
other | 30.000 | € 1,50 | — |
| Jul 1, 2025 |
Karas Eric
Chief Commercial Officer
|
sell | 15.000 | € 16,99 | € 254.861 |
| Jun 25, 2025 |
Shawver Laura
|
grant | 30.000 | — | — |
| Jun 25, 2025 |
Islam Saqib
|
grant | 30.000 | — | — |
| Jun 25, 2025 |
Shah Pratik
|
grant | 30.000 | — | — |
| Jun 25, 2025 |
Dadoo Rajeev
|
grant | 30.000 | — | — |
| Jun 25, 2025 |
Kelly Michael
|
grant | 30.000 | — | — |
| Jun 25, 2025 |
SAUNDERS BRENT L
|
grant | 30.000 | — | — |
| Jun 18, 2025 |
Karas Eric
Chief Commercial Officer
|
other | 30.000 | € 1,50 | — |
| Jun 18, 2025 |
Karas Eric
Chief Commercial Officer
|
sell | 15.000 | € 16,00 | € 240.000 |
| May 20, 2025 |
SAUNDERS BRENT L
|
other | 240.000 | € 1,01 | — |
Belangrijkste Punten
Revenue grew 97,80% annually over 5 years — strong growth
Earnings declined -2241,76% over the past year
Negative free cash flow of -171,21M
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 103,26%
Capital efficient — spends only 0,40% of revenue on capex
Groei
Revenue Growth (5Y)
97,80%
Revenue (1Y)-5,46%
Earnings (1Y)-2241,76%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-92,33%
ROIC-63,72%
Net Margin-203,25%
Op. Margin-212,92%
Veiligheid
Debt / Equity
0,85
Current Ratio7,28
Interest Coverage-69,05
Waardering
P/E Ratio
-4,45
P/B Ratio6,67
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5,46% | Revenue Growth (3Y) | 5200,25% |
| Earnings Growth (1Y) | -2241,76% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97,80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 84,28M | Net Income (TTM) | -171,30M |
| ROE | -92,33% | ROA | -52,28% |
| Gross Margin | 75,77% | Operating Margin | -212,92% |
| Net Margin | -203,25% | Free Cash Flow (TTM) | -171,21M |
| ROIC | -63,72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,85 | Current Ratio | 7,28 |
| Interest Coverage | -69,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,45 | P/B Ratio | 6,67 |
| P/S Ratio | 9,04 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 761,61M | Enterprise Value | 817,26M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 84,28M | 89,15M | 30.000,0 | 1,32M | 5,51M |
| Net Income | -171,30M | 8,00M | -54,37M | -34,68M | -20,24M |
| EPS (Diluted) | -1,74 | 0,08 | -0,57 | -0,87 | -0,70 |
| Gross Profit | 63,86M | 68,59M | 30.000,0 | 1,32M | 5,29M |
| Operating Income | -179,45M | -3,08M | -67,52M | -35,52M | -19,45M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 327,65M | 351,15M | 233,19M | 281,44M | 61,45M |
| Total Liabilities | 213,39M | 94,36M | 2,43M | 8,55M | 92,72M |
| Shareholders' Equity | 114,26M | 256,80M | 230,76M | 272,89M | -31,27M |
| Total Debt | 96,96M | 42.000,0 | 274.000,0 | 481.000,0 | 9,03M |
| Cash & Equivalents | 41,32M | 50,82M | 70,97M | 210,52M | 60,06M |
| Current Assets | 284,90M | 334,30M | 231,56M | 277,70M | 60,73M |
| Current Liabilities | 39,15M | 23,44M | 2,39M | 5,44M | 8,19M |